<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="869">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05149846</url>
  </required_header>
  <id_info>
    <org_study_id>BaMI</org_study_id>
    <nct_id>NCT05149846</nct_id>
  </id_info>
  <brief_title>Pre-conditioning by Balloon-inflation on Myocardial Injury</brief_title>
  <acronym>BaMI</acronym>
  <official_title>Effect of Pre-conditioning by Balloon-inflation on Myocardial Injury During Complex Percutaneous Coronary Intervention - a Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vastra Gotaland Region</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Vastra Gotaland Region</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study objectives:&#xD;
&#xD;
      To test pre-conditioning by three consecutive 60 seconds balloon inflations, spaced 120&#xD;
      seconds apart, followed by 10 minutes rest prior to PCI reduces the risk of myocardial&#xD;
      injury.&#xD;
&#xD;
      Study design:&#xD;
&#xD;
      Single-center, open-label, randomized controlled trial&#xD;
&#xD;
      Study population:&#xD;
&#xD;
      Patients with indication for complex PCI. Patients will be randomized prior to PCI to&#xD;
      pre-conditioning by intracoronary balloon inflation in the target vessel proximal to the&#xD;
      target lesion(s) versus no pre-conditioning followed by a 10-minute waiting period prior to&#xD;
      PCI. PCI will then be performed as per standard of care. Cardiac biomarkers will be drawn at&#xD;
      baseline and 6, 24 and 48 hours after PCI. Cardiac magnetic resonance imaging will be&#xD;
      performed at 48 hours and 6 months post PCI.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this study is to test pre-conditioning by three consecutive 60&#xD;
      seconds balloon inflations, spaced 120 seconds apart followed by 10 minutes rest prior to&#xD;
      percutaneous coronary intervention (PCI) reduces the risk of myocardial injury.&#xD;
&#xD;
      Except for the extended duration of balloon inflations, no study-specific therapy will be&#xD;
      administered to the patients. All patients will receive treatment according to current&#xD;
      guidelines. A follow-up visit will be performed at approximately 6, 24, 48 hours and at 6&#xD;
      months.&#xD;
&#xD;
      The population studied are patients with indication for complex PCI. Patients will be&#xD;
      randomized, after providing written informed consent, prior to PCI to pre-conditioning by&#xD;
      three consecutive intracoronary balloon inflation in the target vessel proximal to the target&#xD;
      lesion(s) versus no pre-conditioning followed by a 10-minute waiting period prior to PCI, PCI&#xD;
      will then be performed as per standard of care. Cardiac biomarkers will be drawn at baseline&#xD;
      and 6 hours, 24 hours and 48 hours after PCI. Cardiac magnetic resonance imaging will be&#xD;
      performed at 48 hours and 6 months post PCI.&#xD;
&#xD;
      Three consecutive balloon occlusions performed for approximate 60 seconds and spaced&#xD;
      approximate 120 seconds apart, followed by a 10-minute waiting period prior to PCI.&#xD;
&#xD;
      Cardiac Magnetic Resonance imaging (CMR) will be used to assess size of myocardial infarction&#xD;
      at 48±6 hours and 6 months±30 days post PCI. CMR examination includes administration of&#xD;
      contrast and one additional blood test (hematocrit, necessary to assess extracellular&#xD;
      volume).&#xD;
&#xD;
      Echocardiography can be used before randomization as per standard of care before PCI.&#xD;
      Echocardiography will be used to assess wall motion score index, left ventricular ejection&#xD;
      fraction at 24 hours and serial examinations can be performed at the discretion of the PI&#xD;
      12-lead Electrocardiogram (ECG) will be used to assess at baseline, during intervention, at&#xD;
      48 hours and serial examinations can be performed at the discretion of the PI.&#xD;
&#xD;
      Apart from the routine laboratory tests, blood samples (troponin-I, troponin-T, creatine&#xD;
      kinase MB fraction [CKMB]) will be collected at baseline, 6±1 hour, 24±6 hours 48±6 hours&#xD;
      after PCI. After collection blood samples will be analyzed at hospitals clinical laboratory&#xD;
      and destructed directly after analyses.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2022</start_date>
  <completion_date type="Anticipated">December 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiac troponin-I</measure>
    <time_frame>within 48 hours</time_frame>
    <description>Area-under the curve of cardiac troponin-I</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Infarct size</measure>
    <time_frame>48 hours</time_frame>
    <description>Procedural infarct size as assessed by cardiac magnetic resonance imaging</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Infarct size</measure>
    <time_frame>6 months</time_frame>
    <description>Procedural infarct size as assessed by cardiac magnetic resonance imaging</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Myocardial Ischemia</condition>
  <arm_group>
    <arm_group_label>Pre-conditioning</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Pre-conditioning by three consecutive 60 seconds balloon inflations, spaced 120 seconds apart followed by 10 minutes rest prior to PCI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controll</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No pre-conditioning, standard care</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pre-conditioning</intervention_name>
    <description>Pre-conditioning by three consecutive 60 seconds balloon inflations, spaced 120 seconds apart followed by 10 minutes rest prior to PCI</description>
    <arm_group_label>Pre-conditioning</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age ≥18 years.&#xD;
&#xD;
          2. Indication for complex PCI, defined as:&#xD;
&#xD;
               1. PCI of a chronic total occlusion&#xD;
&#xD;
               2. Two-stent PCI of a bifurcation lesion.&#xD;
&#xD;
               3. PCI of severely calcified lesion&#xD;
&#xD;
          3. Preprocedural biomarker Troponin-I within normal range&#xD;
&#xD;
          4. Left ventricular ejection fraction &gt;50%&#xD;
&#xD;
          5. Written informed consent obtained&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Previous randomization in the study&#xD;
&#xD;
          2. Decompensated heart failure requiring inotropic /adrenergic support, invasive or&#xD;
             non-invasive ventilation or intra-aortic balloon pump/ventricular assist device&#xD;
             therapy less than 48 hours prior to randomization&#xD;
&#xD;
          3. Recent PCI (&lt;3 months)&#xD;
&#xD;
          4. Known previous myocardial infarction in the target vessel or regional wall motion&#xD;
             abnormalities within the myocardium subtended by the target vessel(s)&#xD;
&#xD;
          5. Any contraindication for Cardiac magnetic resonance imaging&#xD;
&#xD;
          6. Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Björn Redfors, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vastra Gotaland Region</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Björn Redfors, MD, PhD</last_name>
    <phone>+46 31 3427543</phone>
    <email>Bjorn.redfors@wlab.gu.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Margareta Scharin Täng, PhD</last_name>
    <phone>+46 700207968</phone>
    <email>margareta.scharin.tang@vgregion.se</email>
  </overall_contact_backup>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 11, 2021</study_first_submitted>
  <study_first_submitted_qc>November 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 8, 2021</study_first_posted>
  <last_update_submitted>November 24, 2021</last_update_submitted>
  <last_update_submitted_qc>November 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

